'Save younger patients': HC to Centre on Black Fungus drug

Updated : Jun 02, 2021 12:03
|
Editorji News Desk

The Delhi High Court on Tuesday asked the Centre to frame the policy on the distribution of the Liposomal Amphotericin B, a drug used in the treatment of black fungus. It added that younger people and those with better chances of survival should be prioritised, instead of older ones who have lived a full life.

The court asked the Centre to frame policy and file a status report on this regard and listed the matter for Friday. The court asked the Centre to take a policy decision on the distribution of the drug with inputs from medical professionals.

The court also suggested patients should be prioritised -- who have a better chance to survive so at least some lives can be saved.

The Court said that difficult choices have to be made and should be made at this stage. "If we have to choose, the young will have to be chosen. They are the future. 80-year olds are not going to carry this country forward. They have lived their lives," the court said.

Also Read | Is Yellow Fungus more dangerous: causes, symptoms and treatment

Black FungusCovid 19Delhi High Court

Recommended For You

Akhilesh Yadav accuses UP Govt of caste bias in Police postings
editorji | India

Akhilesh Yadav accuses UP Govt of caste bias in Police postings

IAF assists investigation into attack on official
editorji | India

IAF assists investigation into attack on official

editorji | India

Terror attack in Pahalgam claims one life, injures 6 tourists

editorji | India

PM Modi starts two-day Jeddah visit

editorji | India

Mamata Banerjee blames 'outsiders' for Murshidabad violence